Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Akari Therapeutics PLC (NASDAQ:AKTX)

4.50
Delayed Data
As of 4:00pm ET
 -1.90 / -29.69%
Today’s Change
3.18
Today|||52-Week Range
22.20
-36.08%
Year-to-Date
No recent news for Akari Therapeutics PLC.

Today’s Trading

Previous close6.40
Today’s open4.85
Day’s range4.49 - 4.99
Volume1,971,208
Average volume (3 months)291,776
Market cap$75.4M
Dividend yield--
Data as of 4:00pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)+60.20%
Earnings growth (this year)-7,633.33%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book2.19

Competitors

 Today’s
change
Today’s
% change
AZRXAzurRx BioPharma Inc-0.02-0.61%
HSGXHistogenics Corp+0.02+0.95%
KMPHKemPharm Inc0.000.00%
ALTAltimmune Inc-0.02-0.79%
Data as of 3:59pm ET, 10/18/2017

Financials

Next reporting dateNovember 20, 2017
EPS forecast (this quarter)-$0.47
Annual revenue (last year)$0.00
Annual profit (last year)-$18.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
David Horn Solomon
Chief Operating Officer &
Director
Clive Stuart Richardson
Corporate headquarters
London, London & South East

Forecasts